Discover and read the best of Twitter Threads about #publicationbias
Most recents (3)
THREAD: #Prescribers, how do YOU respond to Conflicts of Interest (COI)? 👀
1/8 This thread looks at the issues highlighted in our TI Therapeutics Letter on COI
👉🏼Full Letter: ti.ubc.ca/letter136
#ConflictofInterest #MedEd #MedicalEthics
1/8 This thread looks at the issues highlighted in our TI Therapeutics Letter on COI
👉🏼Full Letter: ti.ubc.ca/letter136
#ConflictofInterest #MedEd #MedicalEthics
2/8 Kirsten is a clinical pharmacist attending a primary care conference👩🏽⚕️
When a keynote speaker reports financial relationships💰with several drug companies, Kirsten takes note🤨
Find out why she prefers #MedEd free of commercial sponsorship: ti.ubc.ca/letter136
When a keynote speaker reports financial relationships💰with several drug companies, Kirsten takes note🤨
Find out why she prefers #MedEd free of commercial sponsorship: ti.ubc.ca/letter136
3/8 Key Opinion Leaders (KOLs)
It's common practice to cultivate “expert” KOLs who are crucial to market success💵of a new drug
Payments to KOLs are reported in USA but similar disclosure does NOT exist in Canada
go.nature.com/39XdVVq
#FinancialInterests #ConflictofInterest
It's common practice to cultivate “expert” KOLs who are crucial to market success💵of a new drug
Payments to KOLs are reported in USA but similar disclosure does NOT exist in Canada
go.nature.com/39XdVVq
#FinancialInterests #ConflictofInterest
Great work by Connor Wells & Shubham Sharma @QueensUHealth asking two important #GlobalHealth questions
1. Is there a #publicationbias against papers from #LMICs?
2. Do oncology RCTs match the global disease burden?
Confirms something we always knew
What we did was this...
1. Is there a #publicationbias against papers from #LMICs?
2. Do oncology RCTs match the global disease burden?
Confirms something we always knew
What we did was this...
We identified 3 problems and 2 facts
We looked at all phase 3 studies in oncology from 2014 to 2017; classified origin of these RCTs based on #WorldBank economic classification of countries. We compared RCT designs and results from HICs and LMICs. The findings were striking…
We looked at all phase 3 studies in oncology from 2014 to 2017; classified origin of these RCTs based on #WorldBank economic classification of countries. We compared RCT designs and results from HICs and LMICs. The findings were striking…
Of 694 RCTs, 636(92%) were led by HICs; 58(8%) by LMICs. This is the first problem – huge imbalance in where research is done. Cancer incidence is strikingly different in HICs & LMICs, with considerable burden in LMICs. How can we accept such a skewed distribution of research?
why i am no longer publishing (my own) #research in #academic journals - a (long) thread 1/38
#AcademicTwitter #AcademicChatter #academicpublishing #academicjournals #peerreview #ecrchat #OpenScience #publicationbias
(some references at the end of the thread)
#AcademicTwitter #AcademicChatter #academicpublishing #academicjournals #peerreview #ecrchat #OpenScience #publicationbias
(some references at the end of the thread)
(i still have a few collaborative papers to write and these will be published properly for the benefit of my co-authors)
i will soon publish a paper on a pre-print server, with no intention of submitting to an academic journal. my reasons for this are manifold 2/38
i will soon publish a paper on a pre-print server, with no intention of submitting to an academic journal. my reasons for this are manifold 2/38
1. #academia is inherently corrupt & the publication model facilitates this:
- unpaid labour (editors, peer-reviewers,& authors [ok, they do get paid by the uni which oft = public funds yet journals privately profit & we see none of this unlike other forms of publishing]) 3/38
- unpaid labour (editors, peer-reviewers,& authors [ok, they do get paid by the uni which oft = public funds yet journals privately profit & we see none of this unlike other forms of publishing]) 3/38
